Uncategorized
NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2023 and provides a business update. “We are successfully expanding relationships with eyecare specialists with product sales from our physician dispensed channel growing 36% over the prior year and increasing in each consecutive quarter so far in 2023. Our multiple sales channels for Avenova have a tremendous impact on one another,